Gilead Sciences, Inc. (GILD) financial statements (2023 and earlier)

Company profile

Business Address 333 LAKESIDE DR
FOSTER CITY, CA 94404
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments6,5207,40824,35230,08925,51011,89514,607
Cash and cash equivalents5,3385,99711,63117,9407,5888,22912,851
Short-term investments1,1821,41112,72112,14917,9223,6661,756
Receivables4,4934,9013,5823,3273,8514,5145,854
Inventory, net of allowances, customer advances and progress billings1,6181,6839228148011,5871,955
Inventory1,6181,6839228148011,5871,955
Prepaid expense     231240
Other current assets     1,062506
Other undisclosed current assets2,1412,0041,4401,6061,6611,1561,601
Total current assets:14,77215,99630,29635,83631,82320,44524,763
Noncurrent Assets
Property, plant and equipment5,1214,9674,5024,0063,2952,8652,276
Long-term investments and receivables1,3095021,4881,42311,18420,48511,601
Long-term investments1,3095021,4881,42311,18420,48511,601
Intangible assets, net (including goodwill)41,78741,23417,90319,85521,25910,14311,419
Goodwill8,3328,1084,1174,1174,1591,1721,172
Intangible assets, net (excluding goodwill)33,45533,12613,78615,73817,1008,97110,247
Prepaid expense     423400
Other noncurrent assets4,9635,7087,4382,5552,7222,2141,056
Other undisclosed noncurrent assets     402324
Total noncurrent assets:53,18052,41131,33127,83938,46036,53227,076
TOTAL ASSETS:67,95268,40761,62763,67570,28356,97751,839
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities6,8505,1803,7873,9294,1843,9964,795
Accounts payable7058447137908141,2061,178
Accrued liabilities6,1454,3363,0743,1393,3702,7903,172
Employee-related liabilities      380
Taxes payable      65
Debt1,5162,7572,4992,7482,747 983
Deferred revenue and credits 202440
Other undisclosed current liabilities3,2443,4603,4733,9284,7045,0213,673
Total current liabilities:11,61011,3979,75910,60511,6359,2199,891
Noncurrent Liabilities
Long-term debt and lease obligation25,17928,64522,09424,57430,79526,34621,195
Long-term debt, excluding current maturities25,17928,64522,09424,57430,79526,34621,195
Liabilities, other than long-term debt10,09910,1447,1246,9627,3522,0491,638
Accounts payable and accrued liabilities4,7675,0166,1155,9226,7941,7531,243
Deferred income tax liabilities4,356  
Other liabilities9765,1281,0091,040558296395
Total noncurrent liabilities:35,27838,78929,21831,53638,14728,39522,833
Total liabilities:46,88850,18638,97742,14149,78237,61432,724
Temporary equity, carrying amount      2
Stockholders' equity
Stockholders' equity attributable to parent21,06918,20222,52521,38720,44218,88718,534
Common stock1111111
Additional paid in capital4,6613,8803,0512,2821,264454444
Accumulated other comprehensive income (loss)83(60)858016527888
Retained earnings16,32414,38119,38819,02419,01218,15418,001
Stockholders' equity attributable to noncontrolling interest(5)1912514759476579
Total stockholders' equity:21,06418,22122,65021,53420,50119,36319,113
TOTAL LIABILITIES AND EQUITY:67,95268,40761,62763,67570,28356,97751,839

Income statement (P&L) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues27,30524,68922,44922,12726,10730,39032,639
Revenue, net26,10730,39032,639
Cost of revenue
(Cost of Goods and Services Sold)
(6,601)(4,572)(4,675)(4,853)(4,371)(4,261)(4,006)
Gross profit:20,70420,11717,77417,27421,73626,12928,633
Operating expenses(10,786)(16,046)(14,287)(9,894)(7,612)(8,928)(6,440)
Other undisclosed operating income  800820 432 
Operating income:9,9184,0714,2878,20014,12417,63322,193
Nonoperating income (expense)(639)(1,418)1,868676523428154
Investment income, nonoperating21(51)22(2)  117
Interest and debt expense(1,001)(984)(995)(1,077)(1,118)(964)(688)
Income from continuing operations before income taxes:8,2781,6695,1607,79913,52917,09721,659
Income tax expense (benefit)(2,077)(1,580)204(2,339)(8,885)(3,609)(3,553)
Net income:6,201895,3645,4604,64413,48818,106
Net income (loss) attributable to noncontrolling interest243422(5)(16)132
Net income available to common stockholders, diluted:6,2251235,3865,4554,62813,50118,108

Comprehensive Income ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income:6,201895,3645,4604,64413,48818,106
Other comprehensive income (loss)143(145)5208(113)190(213)
Comprehensive income (loss):6,344(56)5,3695,6684,53113,67817,893
Comprehensive income (loss), net of tax, attributable to noncontrolling interest243422(5)(16)132
Comprehensive income (loss), net of tax, attributable to parent:6,368(22)5,3915,6634,51513,69117,895

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: